You have full text access to this OnlineOpen article

Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block

  1. Shashank M. Dravid1,
  2. Kevin Erreger3,
  3. Hongjie Yuan1,
  4. Katherine Nicholson4,
  5. Phuong Le1,
  6. Polina Lyuboslavsky1,
  7. Antoine Almonte1,
  8. Ernest Murray2,
  9. Cara Mosley2,
  10. Jeremy Barber1,
  11. Adam French1,
  12. Robert Balster5,
  13. Thomas F. Murray6,
  14. Stephen F. Traynelis1

Article first published online: 4 MAY 2007

DOI: 10.1113/jphysiol.2006.124958

Issue

The Journal of Physiology

The Journal of Physiology

Volume 581, Issue 1, pages 107–128, May 2007

Additional Information

How to Cite

Dravid, S. M., Erreger, K., Yuan, H., Nicholson, K., Le, P., Lyuboslavsky, P., Almonte, A., Murray, E., Mosley, C., Barber, J., French, A., Balster, R., Murray, T. F. and Traynelis, S. F. (2007), Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block. The Journal of Physiology, 581: 107–128. doi: 10.1113/jphysiol.2006.124958

Author Information

  1. 1

    Departments of Pharmacology and

  2. 2

    Chemistry, Emory University, Atlanta, GA 30322, USA

  3. 3

    Department of Molecular Physiology and Biophysics, Vanderbilt University, 465 21st Avenue S, MRB III Room 7124, Nashville, TN 37232, USA

  4. 4

    Department of Pharmacology and Toxicology and

  5. 5

    Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA 23298, USA

  6. 6

    Department of Pharmacology, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA

*Corresponding author S. Dravid: Department of Pharmacology, Emory University School of Medicine, Rollins Research Centre, 1510 Clifton Road, Atlanta, GA 30322-3090, USA. Email: smdravid@pharm.emory.edu

Publication History

  1. Issue published online: 4 MAY 2007
  2. Article first published online: 4 MAY 2007
  3. (Received 14 November 2006; accepted after revision 8 February 2007; first published online 15 February 2007)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (843K)

References

  • Albers GW, Goldberg MP & Choi DW (1989). N-Methyl-d-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 25, 398–403.
    Direct Link:
  • Andine P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E & Sandberg M (1999). Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 290, 1393–1408.
  • Antonov SM, Gmiro VE & Johnson JW (1998). Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block. Nat Neurosci 1, 451–461.
  • Antonov SM & Johnson JW (1999). Permeant ion regulation of N-methyl-d-aspartate receptor channel block by Mg2+. Proc Natl Acad Sci U S A 96, 14571–14576.
  • Balster RL (1991). Drug abuse potential evaluation in animals. Br J Addict 86, 1549–1558.
    Direct Link:
  • Balster RL & Willetts J (1988). Receptor mediation of the discriminative stimulus properties of phencyclidine and σ-opioid agonists. Psychopharmacol Ser 4, 122–135.
  • Banke TG, Dravid SM & Traynelis SF (2005). Protons trap NR1/NR2B NMDA receptors in a nonconducting state. J Neurosci 25, 42–51.
  • Baselt RC (2004). Disposition of Toxic Drugs and Chemicals in Man, 7th edn. Biomedical Publications, Foster City , CA , USA .
  • Benveniste M & Mayer ML (1992). Effect of extracellular pH on the potency of N-methyl-d-aspartic acid receptor competitive antagonists. Mol Pharmacol 42, 679–686.
  • Blanpied TA, Boeckman FA, Aizenman E & Johnson JW (1997). Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77, 309–323.
  • Blanpied TA, Clarke RJ & Johnson JW (2005). Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 25, 3312–3322.
  • Bolshakov KV, Gmiro VE, Tikhonov DB & Magazanik LG (2003). Determinants of trapping block of N-methyl-d-aspartate receptor channels. J Neurochem 87, 56–65.
    Direct Link:
  • Bormann J (1989). Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels. Eur J Pharmacol 166, 591–592.
  • Casadio R & Melandri BA (1977). The behavior of 9-aminoacridine as an indicator of transmembrane pH difference in liposomes of natural bacterial phospholipids. J Bioenerg Biomembr 9, 17–29.
  • Chesler M & Kaila K (1992). Modulation of pH by neuronal activity. Trends Neurosci 15, 396–402.
  • Choi DW (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58, 293–297.
  • Choi DW (1992). Excitotoxic cell death. J Neurobiol 23, 1261–1276.
    Direct Link:
  • Choi YB & Lipton SA (1999). Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 23, 171–180.
  • Church J, Zeman S & Lodge D (1988). The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 69, 702–709.
  • Clarke RJ & Johnson JW (2006). NMDA receptor NR2 subunit dependence of the slow component of magnesium unblock. J Neurosci 26, 5825–5834.
  • Costa AC & Albuquerque EX (1994). Dynamics of the actions of tetrahydro-9-aminoacridine and 9-aminoacridine on glutamatergic currents: concentration-jump studies in cultured rat hippocampal neurons. J Pharmacol Exp Ther 268, 503–514.
  • Dilmore JG & Johnson JW (1998). Open channel block and alteration of N-methyl-d-aspartic acid receptor gating by an analog of phencyclidine. Biophys J 75, 1801–1816.
  • Dingledine R, Borges K, Bowie D & Traynelis SF (1999). The glutamate receptor ion channels. Pharmacol Rev 51, 7–61.
  • Dirnagl U, Iadecola C & Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391–397.
  • Dravid SM, Baden DG & Murray TF (2004). Brevetoxin activation of voltage-gated sodium channels regulates Ca dynamics and ERK1/2 phosphorylation in murine neocortical neurons. J Neurochem 89, 739–749.
    Direct Link:
  • Ellison G (1995). The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioural and anatomical models of the dementias. Brain Res Brain Res Rev 20, 250–267.
  • Erdo SL & Schafer M (1991). Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-d-aspartate. Eur J Pharmacol 198, 215–217.
  • Erreger K, Chen PE, Wyllie DJ & Traynelis SF (2004). Glutamate receptor gating. Crit Rev Neurobiol 16, 187–224.
  • Erreger K, Dravid SM, Banke TG, Wyllie DJ & Traynelis SF (2005a). Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563, 345–358.
    Direct Link:
  • Erreger K, Geballe MT, Dravid SM, Snyder JP, Wyllie DJ & Traynelis SF (2005b). Mechanism of partial agonism at NMDA receptors for a conformationally restricted glutamate analog. J Neurosci 25, 7858–7866.
  • France CP, Moerschbaecher JM & Woods JH (1991). MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination. J Pharmacol Exp Ther 257, 727–734.
  • Freudenthaler S, Meineke I, Schreeb KH, Boakye E, Gundert-Remy U & Gleiter CH (1998). Influence of urine pH and urinary flow on the renal excretion of memantine. Br J Clin Pharmacol 46, 541–546.
    Direct Link:
  • Genovese RF & Lu XC (1991). Effects of MK-801 stereoisomers on schedule-controlled behavior in rats. Psychopharmacology (Berl) 105, 477–480.
  • Geter-Douglass B & Witkin JM (1997). Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. Psychopharmacology (Berl) 133, 43–50.
  • Giffard RG, Monyer H, Christine CW & Choi DW (1990). Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res 506, 339–342.
  • Gill R, Foster AC & Woodruff GN (1987). Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 7, 3343–3349.
  • Halliwell RF, Peters JA & Lambert JJ (1989). The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture. Br J Pharmacol 96, 480–494.
  • Higgins GA, Ballard TM, Huwyler J, Kemp JA & Gill R (2003). Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology 44, 324–341.
  • Hille B (1977). The pH-dependent rate of action of local anesthetics on the node of Ranvier. J Gen Physiol 69, 475–496.
  • Hiramatsu M, Cho AK & Nabeshima T (1989). Comparison of the behavioural and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166, 359–366.
  • Holtzman SG (1990). Caffeine as a model drug of abuse. Trends Pharmacol Sci 11, 355–356.
  • Huettner JE & Bean BP (1988). Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A 85, 1307–1311.
  • Jahr CE (1992). High probability opening of NMDA receptor channels by l-glutamate. Science 255, 470–472.
  • Janssens N & Lesage AS (2001). Glutamate receptor subunit expression in primary neuronal and secondary glial cultures. J Neurochem 77, 1457–1474.
    Direct Link:
  • Johnson JW & Kotermanski SE (2006). Mechanism of action of memantine. Curr Opin Pharmacol 6, 61–67.
  • Kashiwagi K, Pahk AJ, Masuko T, Igarashi K & Williams K (1997). Block and modulation of N-methyl-d-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits. Mol Pharmacol 52, 701–713.
  • Khanna JM, Wu PH, Weiner J & Kalant H (1991). NMDA antagonist inhibits rapid tolerance to ethanol. Brain Res Bull 26, 643–645.
  • Kochhar A, Zivin JA & Mazzarella V (1991). Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia. J Neurotrauma 8, 175–186.
  • Koek W, Woods JH & Colpaert FC (1990). N-Methyl-d-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. J Pharmacol Exp Ther 253, 1017–1025.
  • Koh JY & Choi DW (1987). Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Meth 20, 83–90.
  • Kornhuber J, Weller M, Schoppmeyer K & Riederer P (1994). Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl 43, 91–104.
  • Lee JM, Zipfel GJ & Choi DW (1999). The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7–A14.
  • LePage KT, Ishmael JE, Low CM, Traynelis SF & Murray TF (2005). Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors. Neuropharmacology 49, 1–16.
  • Li JH, Wang YH, Wolfe BB, Krueger KE, Corsi L, Stocca G & Vicini S (1998). Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons. Eur J Neurosci 10, 1704–1715.
    Direct Link:
  • Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, Williams K, Traynelis SF & Zheng F (2003). Molecular determinants of proton-sensitive N-methyl-d-aspartate receptor gating. Mol Pharmacol 63, 1212–1222.
  • Low CM, Zheng F, Lyuboslavsky P & Traynelis SF (2000). Molecular determinants of coordinated proton and zinc inhibition of N-methyl-d-aspartate NR1/NR2A receptors. Proc Natl Acad Sci U S A 97, 11062–11067.
  • MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW, Schneiderman JH & Pennefather PS (1991). Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol 432, 483–508.
  • MacDonald JF & Nowak LM (1990). Mechanisms of blockade of excitatory amino acid receptor channels. Trends Pharmacol Sci 11, 167–172.
  • Meldrum BS, Akbar MT & Chapman AG (1999). Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res 36, 189–204.
  • Moffat AC, Osselton MD & Widdop B (2004). Clarke's Analysis of Drugs and Poisons, 3rd edn, vol. 2. Pharmaceutical Press, London .
  • Monaghan DT, Andaloro VJ & Skifter DA (1998). Molecular determinants of NMDA receptor pharmacological diversity. Prog Brain Res 116, 171–190.
  • Monaghan DT & Larsen H (1997). NR1 and NR2 subunit contributions to N-methyl-d-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 280, 614–620.
  • Mori H, Masaki H, Yamakura T & Mishina M (1992). Identification by mutagenesis of a Mg2+-block site of the NMDA receptor channel. Nature 358, 673–675.
  • Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P, Traynelis SF & Dingledine R (1998). Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci 1, 659–667.
  • Mott DD, Erreger K, Banke TG & Traynelis SF (2001). Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy. J Physiol 535, 427–443.
    Direct Link:
  • Mozayani A (2003). Phencyclidine – effects on human performance and behavior. Forensic Sci Rev 15, 61–74.
  • Myers SJ, Geballe MT, Le P, Lyuboslavsky PN, Dingledine R, Snyder JP & Traynelis SF (2006). pH dependence of phosphono-derivative NMDA receptor antagonists. Abstract Viewer and Itinerary Planner, prog. no. 623.2. Society for Neuroscience 2006 Online.
  • Nedergaard M, Kraig RP, Tanabe J & Pulsinelli WA (1991). Dynamics of interstitial and intracellular pH in evolving brain infarct. Am J Physiol Regul Integr Comp Physiol 260, R581–R588.
  • Nicholson KL, Hayes BA & Balster RL (1999). Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology (Berl) 146, 49–59.
  • Obrenovitch TP & Urenjak J (1997). Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? J Neurotrauma 14, 677–698.
  • Pahk AJ & Williams K (1997). Influence of extracellular pH on inhibition by ifenprodil at N-methyl-d-aspartate receptors in Xenopus oocytes. Neurosci Lett 225, 29–32.
  • Park CK, Nehls DG, Graham DI, Teasdale GM & McCulloch J (1988). The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 24, 543–551.
    Direct Link:
  • Parsons CG, Gruner R, Rozental J, Millar J & Lodge D (1993). Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32, 1337–1350.
  • Raffa RB, Ortegon ME, Robisch DM & Martin GE (1989). In vivo demonstration of the enhancement of MK-801 by l-glutamate. Life Sci 44, 1593–1599.
  • Sackin H, Nanazashvili M, Palmer LG, Krambis M & Walters DE (2005). Structural locus of the pH gate in the Kir1.1 inward rectifier channel. Biophys J 88, 2597–2606.
  • Sattler R, Charlton MP, Hafner M & Tymianski M (1998). Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem 71, 2349–2364.
    Direct Link:
  • Sattler R & Tymianski M (2001). Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24, 107–129.
  • Schulte U, Hahn H, Konrad M, Jeck N, Derst C, Wild K, Weidemann S, Ruppersberg JP, Fakler B & Ludwig J (1999). pH gating of ROMK (Kir1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci U S A 96, 15298–15303.
  • Schwarz W, Palade PT & Hille B (1977). Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. Biophys J 20, 343–368.
  • Slater B, McCormack A, Avdeef A & Comer JE (1994). pH-metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values. J Pharm Sci 83, 1280–1283.
    Direct Link:
  • Sobolevskii AI & Khodorov BI (2002). Blocker studies of the functional architecture of the NMDA receptor channel. Neurosci Behav Physiol 32, 157–171.
  • Sobolevsky AI, Koshelev SG & Khodorov BI (1999). Probing of NMDA channels with fast blockers. J Neurosci 19, 10611–10626.
  • Spector R (1988). Transport of amantadine and rimantadine through the blood–brain barrier. J Pharmacol Exp Ther 244, 516–519.
  • Stern P, Behe P, Schoepfer R & Colquhoun D (1992). Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc Biol Sci 250, 271–277.
  • Tang CM, Dichter M & Morad M (1990). Modulation of the N-methyl-d-aspartate channel by extracellular H+. Proc Natl Acad Sci U S A 87, 6445–6449.
  • Thornberg SA & Saklad SR (1996). A review of NMDA receptors and the phencyclidine model of schizophrenia. Pharmacotherapy 16, 82–93.
  • Tombaugh GC & Sapolsky RM (1993). Evolving concepts about the role of acidosis in ischemic neuropathology. J Neurochem 61, 793–803.
    Direct Link:
  • Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P & Powers JL (1998). Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 18, 6163–6175.
  • Traynelis SF & Cull-Candy SG (1990). Proton inhibition of N-methyl-d-aspartate receptors in cerebellar neurons. Nature 345, 347–350.
  • Traynelis SF & Cull-Candy SG (1991). Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones. J Physiol 433, 727–763.
  • Traynelis SF & Wahl P (1997). Control of rat GluR6 glutamate receptor open probability by protein kinase A and calcineurin. J Physiol 503, 513–531.
    Direct Link:
  • Tricklebank MD, Singh L, Oles RJ, Preston C & Iversen SD (1989). The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167, 127–135.
  • Vyklicky L Jr, Vlachova V & Krusek J (1990). The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones. J Physiol 430, 497–517.
  • Wang CX & Shuaib A (2005). NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord 4, 143–151.
  • Wiley JL, Li H & Balster RL (1997). Discriminative stimulus effects of site-selective N-methyl-d-aspartate antagonists in NPC 17742-trained rats and squirrel monkeys. Psychopharmacology (Berl) 132, 382–388.
  • Willetts J & Balster RL (1988). Phencyclidine-like discriminative stimulus properties of MK-801 in rats. Eur J Pharmacol 146, 167–169.
  • Wollmuth LP, Kuner T & Sakmann B (1998). Intracellular Mg2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel. J Physiol 506, 33–52.
    Direct Link:
  • Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN & Iversen LL (1986). The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc Natl Acad Sci U S A 83, 7104–7108.
  • Xu H, Yang Z, Cui N, Chanchevalap S, Valesky WW & Jiang C (2000). A single residue contributes to the difference between Kir4.1 and Kir1.1 channels in pH sensitivity, rectification and single channel conductance. J Physiol 528, 267–277.
    Direct Link:
  • Yamakura T, Sakimura K & Shimoji K (2000). N-Methyl-d-aspartate receptor channel block by meperidine is dependent on extracellular pH. Anesth Analg 90, 928–932.
  • Yang Z, Xu H, Cui N, Qu Z, Chanchevalap S, Shen W & Jiang C (2000). Biophysical and molecular mechanisms underlying the modulation of heteromeric Kir4.1-Kir5.1 channels by CO2 and pH. J Gen Physiol 116, 33–45.
  • Yuan H, Erreger K, Dravid SM & Traynelis SF (2005). Conserved structural and functional control of N-methyl-d-aspartate receptor gating by transmembrane domain M3. J Biol Chem 280, 29708–29716.
  • Zarei MM & Dani JA (1995). Structural basis for explaining open-channel blockade of the NMDA receptor. J Neurosci 15, 1446–1454.
  • Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ & Traynelis SF (2001). Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci 4, 894–901.
  • Zhu Y & Auerbach A (2001). Na+ occupancy and Mg2+ block of the N-methyl-d-aspartate receptor channel. J Gen Physiol 117, 275–286.
View Full Article (HTML) Get PDF (843K)